Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael I Barton

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Communications Biology|September 13, 2024
Ligand requirements for immunoreceptor triggeringMichael I Barton, Rachel L Paterson, Eleanor M Denham, et al.
Plos Computational Biology|March 2, 2022
Missense variants in human ACE2 strongly affect binding to SARS-CoV-2 Spike providing a mechanism for ACE2 mediated genetic risk in Covid-19: A case study in affinity predictions of interface variantsStuart A MacGowan, Michael I Barton, Mikhail Kutuzov, et al.
Elife|August 26, 2021
Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kineticsMichael I Barton, Stuart A MacGowan, Mikhail A Kutuzov, et al.
Plos Biology|December 10, 2019
A generic cell surface ligand system for studying cell-cell recognitionEleanor M Denham, Michael I Barton, Susannah M Black, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 10, 2026
Mixed-mobility supported lipid bilayers uncover the role of immobilized ICAM1 on T cell activation and immune synapse organizationAlexander Leithner, Audun Kvalvaag, Tanmay Mitra, et al.
The EMBO Journal|January 4, 2024
Using CombiCells, a platform for titration and combinatorial display of cell surface ligands, to study T-cell antigen sensitivity modulation by accessory receptorsAshna Patel, Violaine Andre, Sofia Bustamante Eguiguren, et al.
Nature Communications|March 21, 2025
Publisher Correction: The molecular reach of antibodies crucially underpins their viral neutralisation capacityAnna Huhn, Daniel Nissley, Daniel B Wilson, et al.
Nature Communications|January 2, 2025
The molecular reach of antibodies crucially underpins their viral neutralisation capacityAnna Huhn, Daniel Nissley, Daniel B Wilson, et al.
Cell Reports. Medicine|May 9, 2024
A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinityChang Liu, Daming Zhou, Aiste Dijokaite-Guraliuc, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Communications Biology|September 13, 2024
Ligand requirements for immunoreceptor triggeringMichael I Barton, Rachel L Paterson, Eleanor M Denham, et al.
Plos Computational Biology|March 2, 2022
Missense variants in human ACE2 strongly affect binding to SARS-CoV-2 Spike providing a mechanism for ACE2 mediated genetic risk in Covid-19: A case study in affinity predictions of interface variantsStuart A MacGowan, Michael I Barton, Mikhail Kutuzov, et al.
Elife|August 26, 2021
Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kineticsMichael I Barton, Stuart A MacGowan, Mikhail A Kutuzov, et al.
Plos Biology|December 10, 2019
A generic cell surface ligand system for studying cell-cell recognitionEleanor M Denham, Michael I Barton, Susannah M Black, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 10, 2026
Mixed-mobility supported lipid bilayers uncover the role of immobilized ICAM1 on T cell activation and immune synapse organizationAlexander Leithner, Audun Kvalvaag, Tanmay Mitra, et al.
The EMBO Journal|January 4, 2024
Using CombiCells, a platform for titration and combinatorial display of cell surface ligands, to study T-cell antigen sensitivity modulation by accessory receptorsAshna Patel, Violaine Andre, Sofia Bustamante Eguiguren, et al.
Nature Communications|March 21, 2025
Publisher Correction: The molecular reach of antibodies crucially underpins their viral neutralisation capacityAnna Huhn, Daniel Nissley, Daniel B Wilson, et al.
Nature Communications|January 2, 2025
The molecular reach of antibodies crucially underpins their viral neutralisation capacityAnna Huhn, Daniel Nissley, Daniel B Wilson, et al.
Cell Reports. Medicine|May 9, 2024
A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinityChang Liu, Daming Zhou, Aiste Dijokaite-Guraliuc, et al.
Pageof 1